Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for tr...See more
Headquarter United States of America |
Year founded 2014 (10 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Research Study Coordinator
General Manager